This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Mouse Coagulation Factor VII (F7)
Product Overview
BioVenic's Recombinant Mouse Coagulation Factor VII (F7) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 14.7 kDa. The purity is> 95%.
Specifications
Target Information
Mouse Coagulation Factor VII (F7) is a vitamin K-dependent serine protease that plays a pivotal role in initiating the extrinsic pathway of the coagulation cascade. It circulates in the blood as a zymogen and is activated to FVIIa upon tissue injury, in the presence of tissue factor (TF) and calcium ions. Activated FVIIa then catalyzes the conversion of factor X to factor Xa and factor IX to factor IXa, propagating the coagulation cascade, leading to thrombin generation, fibrin deposition, and ultimately clot formation. In mice, F7 deficiency results in severe bleeding disorders, highlighting its essential role in hemostasis. Additionally, F7 is primarily synthesized in the liver and is expressed in various tissues, including the cardiovascular system and hematopoietic system.
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -80°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in PBS or others. Aliquot the reconstituted solution to minimize freeze-thaw cycles.